Home  /  Resource Library  /  Time to Second Treatment As a Proxy for Overall Survival in CLL/SLL: Identifying Risk Factors to Help Guide Treatment Selection

Time to Second Treatment As a Proxy for Overall Survival in CLL/SLL: Identifying Risk Factors to Help Guide Treatment Selection

ASH 2019: Study examined the time to second treatment as a predictor of overall survival in chronic lymphocytic leukemia.